Literature DB >> 29260245

[Cerebral amyloid angiopathy associated with inflammation].

J Schaumberg1, M Trauscheid2, B Eckert3, D Petersen4, W Schulz-Schaeffer5, J Röther6, W Heide2.   

Abstract

Cerebral amyloid angiopathy (CAA) associated with inflammation is a rare form of a potentially reversible encephalopathy in a subgroup of patients with CAA. The cerebral amyloid deposition can in isolated cases induce an inflammation predominantly of the cerebral blood vessels and a multifocal edema of the cerebral white matter. The courses can occur as monophasic, relapsing remitting and primarily progressive forms. We present seven cases with different courses of the disease and give an overview of the pathophysiology, clinical aspects and treatment of the disease with reference to the current literature. The cases presented show a very different and often difficult differential diagnostic clinical picture and all showed a significant improvement under steroid medication without signs of recurrence of the disease during the course. The recognition and early consistent treatment of inflammatory forms of CAA with and without direct inflammatory involvement of vessels can be decisive for successful treatment.

Entities:  

Keywords:  Amyloid-beta related angiitis (ABRA); Cerebral amyloid angiopathy (CAA); Inflammation; Primary angiitis of the central nervous system; Superficial siderosis

Mesh:

Year:  2018        PMID: 29260245     DOI: 10.1007/s00115-017-0469-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  30 in total

1.  Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report.

Authors:  J C DiFrancesco; M Brioschi; L Brighina; C Ruffmann; E Saracchi; G Costantino; G Galimberti; E Conti; N A Curtò; L Marzorati; P Remida; F Tagliavini; M Savoiardo; C Ferrarese
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

Review 2.  The Inflammatory Form of Cerebral Amyloid Angiopathy or "Cerebral Amyloid Angiopathy-Related Inflammation" (CAARI).

Authors:  Howard S Kirshner; Michael Bradshaw
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

Review 3.  Amyloid beta-related angiitis--a case report and comprehensive review of literature of 94 cases.

Authors:  Abhijeet Danve; Marjorie Grafe; Atul Deodhar
Journal:  Semin Arthritis Rheum       Date:  2014-02-11       Impact factor: 5.532

4.  Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis.

Authors:  Shuguang Chu; Feijia Xu; Ya Su; Hong Chen; Xin Cheng
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

5.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Authors:  D R Premkumar; D L Cohen; P Hedera; R P Friedland; R N Kalaria
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Course of cerebral amyloid angiopathy-related inflammation.

Authors:  C Kinnecom; M H Lev; L Wendell; E E Smith; J Rosand; M P Frosch; S M Greenberg
Journal:  Neurology       Date:  2007-04-24       Impact factor: 9.910

7.  Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome.

Authors:  Matia Martucci; Silvana Sarria; Manuel Toledo; Pilar Coscojuela; Carla Vert; Sahyly Siurana; Cristina Auger; Alex Rovira
Journal:  Neuroradiology       Date:  2014-02-04       Impact factor: 2.804

Review 8.  The pathophysiology and clinical presentation of cerebral amyloid angiopathy.

Authors:  Eitan Auriel; Steven Mark Greenberg
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

9.  High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.

Authors:  M O McCarron; J A Nicoll
Journal:  Neurosci Lett       Date:  1998-05-08       Impact factor: 3.046

10.  β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.

Authors:  Ellis S van Etten; Marcel M Verbeek; Jeroen van der Grond; Ronald Zielman; Sanneke van Rooden; Erik W van Zwet; Anna M van Opstal; Joost Haan; Steven M Greenberg; Mark A van Buchem; Marieke J H Wermer; Gisela M Terwindt
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.